The Food and Drug Administration (FDA) will propose approval and reclassification of cranial electrotherapy stimulation (CES) devices for the treatment of insomnia, depression, and anxiety. In a document to be published...
Read MoreCleveland Medical Devices Inc (CleveMed) has been awarded a group purchasing agreement for Sleep Diagnostic Services with Premier Inc. Effective June 1, 2014, the new agreement allows Premier members, at their discretion, to...
Read MoreCPAP, the most widely prescribed therapy for treatment of obstructive sleep apnea (OSA), resulted in significantly lower blood pressure compared to either nocturnal supplemental oxygen or an educational control treatment,...
Read More
Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with a variety of...
Read More
SleepMapper is a mobile application and website that employs theoretically-driven and empirically-tested interventions designed to improve adherence to PAP therapy. Details are available in the white paper.
Read More